Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 9, 2003, Pages 876-881

  Stanford, Janet L ^a,b,c   Sabacan, Leah P ^a   Noonan, Elizabeth A ^a   Iwasaki, Lori ^a   Shu, Jianfen ^a   Feng, Ziding ^a   Ostrander, Elaine A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Division of Public Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; LEUCINE; SERINE; THREONINE;

ADULT; ARTICLE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE; GENE ELAC2; GENE HPC2; GENETIC POLYMORPHISM; GENOTYPE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SCORING SYSTEM; UNITED STATES;

ADENOCARCINOMA; ADULT; ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HOMOZYGOTE; HUMANS; LEUCINE; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEOPLASM PROTEINS; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS; VARIATION (GENETICS);

EID: 0141786965     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., and Thun, M. J. Cancer statistics, 2003. CA - Cancer J. Clin., 53: 5-26, 2003.
2. Steinberg, G. D., Carter, B. S., Beaty, T. H., Childs, B., and Walsh, P. C. Family history and the risk of prostate cancer. Prostate, 17: 337-347, 1990.
3. Spitz, M. R., Currier, R. D., Fueger, J. J., Babaian, R. J., and Newell, G. R. Familial patterns of prostate cancer: a case-control analysis. J. Urol., 146: 1305-1307, 1991.
4. Whittemore, A. S., Wu, A. H., Kolonel, L. N., John, E. M., Gallagher, R. P., Howe, G. R., West, D. W., Teh, C. Z., and Stamey, T. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am. J. Epidemiol., 141: 732-740, 1995.
5. Hayes, R. B., Liff, J. M., Potter, L. M., Greenberg, R. S., Schoenberg, J. B., Schwartz, A. G., Swanson, G. M., Swanson, G. M., Silverman, D. T., Brown, L. M., Hoover, R. N., and Fraumeni, J. F., Jr. Prostate cancer risk in U. S. blacks and whites with a family history of cancer. Int. J. Cancer, 60: 361-364, 1995.
6. Lesko, S. M., Rosenberg, L., and Shapiro, S. Family history and prostate cancer risk. Am. J. Epidemiol., 144: 1041-1047, 1996.
7. Ghadirian, P., Howe, G., Hislop, T., and Maisonneuve, P. Family history of prostate cancer: a multi-center case-control study in Canada. Int. J. Cancer, 70: 679-681, 1997.
8. Goldgar, D. E., Easton, D. F., Cannon-Albright, L. A., and Skolnick, M. H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst. (Bethesda), 86: 1600-1608, 1994.
9. Grönberg, H., Damber, L., and Damber, J. E. Familial prostate cancer in Sweden. Cancer (Phila.), 77: 138-143, 1996.
10. Cerhan, J. R., Parker, A. S., Putnam, S. D., Chiu, B. C-H., Lynch, C. F., Cohen, M. B., Torner, J. C., and Cantor, K. P. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol. Biomark. Prev., 8: 53-60, 1999.
11. Stanford. J. L., and Ostrander. E. A. Familial prostate cancer. Epidemiol. Rev., 23: 19-23, 2001.
12. Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B., and Walsh, P. C. Mendelian inheritance of familial prostate cancer. Proc. Natl. Acad. Sci. USA, 89: 3367-3371, 1992.
13. Grönberg, H., Damber, L., Damber, J-E., and Iselius, L. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am. J. Epidemiol., 146: 552-557, 1997.
14. Schaid, D. J., McDonnell, S. K., Blute, M. L., and Thibodeau, S. N. Evidence for autosomal dominant inheritance of prostate cancer. Am. J. Hum. Genet., 62: 1425-1438, 1998.
15. Smith, J. R., Freije, D., Carpten, J. D., Gronberg, H., Xu, J., Isaacs, S. D., Brownstein, M. J., Bova, G. S., Guo, H., Bujnovszky, P., Nusskern, D. R., Camber, J. E., Bergh, A., Emanuelsson, M., Kallioniemi, O. P., Walker-Daniels, J., Bailey-Wilson, J. E., Beaty, T. H., Meyers, D. A., Walsh, P. C., Collins, F. S., Trent, J. M., and Isaacs, W. B. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science (Wash. DC), 274: 1371-1374, 1996.
16. Berthon, P., Valeri, A., Cohen-Akenine, A., Drelon, E., Paiss, T., Wohr, G., Latil, A., Millasseau, P., Mellah, I., Cohen, N., Blanche, H., Bellane-Chantelot, C., Demenais, F., Teillac, P., Le Duc, A., de Petriconi, R., Hautmann, R., Chumakov, I., Bachner, L., Maitland, N. J., Lidereau, R., Vogel, W., Fournier, G., Mangin, P., and Cussenot, O. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am. J. Hum. Genet., 62: 1416-1424, 1998.
17. Gibbs, M., Stanford, J. L., McIndoe, R. A., Jarvik, G. P., Kolb, S., Goode, E. L., Chakrabarti, L., Schuster, E. F., Buckley, V. A., Miller, E. L., Brandzel, S., Li, S., Hood, L., and Ostrander, E. A. Evidence for a rare prostate cancer susceptibility locus at chromosome 1p36. Am. J. Hum. Genet., 64: 776-787, 1999.
18. Berry, R., Schroeder, J. J., French, A. J., McDonnell, S. K., Peterson, B. J., Cunningham, J. M., Thibodeau, S. N., and Schaid, D. J. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am. J. Hum. Genet., 67: 82-91, 2000.
19. Xu, J., Meyers, D., Freije, D., Isaacs, S., Wiley, K., Nusskern, D., Ewing, C., Wilkens, E., Bujnovszky, P., Bova, G. S., Walsh, P., Isaacs, W., Schleutker, J., Matikainen, M., Tammela, T., Visakorpi, T., Kallioniemi, O. P., Berry, R., Schaid, D., French, A., Mc Donnell, S., Schroeder, J., Blute, M., Thibodeau, S., and Trent, J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat. Genet. (Letter), 20: 175-179, 1998.
20. Tavtigian, S. V., Simard, J., Teng, D. H. F., Abtin, V., Baumgard, M., Beck, A., Camp, N. J., Carillo, A. R., Chen, Y., Dayananth, P., Desrochers, M., Dumont, M., Famham, J. M., Frank, D., Frye, C., Ghaffari, S., Gupte, J. S., Hu, R., Iliev, D., Janecki, T., Kort, E. N., Laity, K. E., Leavitt, A., Leblanc, G., McArthur-Morrison, J., Pederson, A., Penn, B., Peterson, K. T., Reid, J. E., Richards, S., Schroeder, M., Smith, R., Snyder, S. C., Swedlund, B., Swensen, J., Thomas, A., Tranchant, M., Woodland, A-M., Labrie, F., Skolnick, M. H., Neuhausen, S., Rommens, J., and Cannon-Albright, L. A. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat. Genet., 27: 172-180, 2001.
21. Ostrander, E. A., and Stanford, J. L. Genetics of prostate cancer: too many loci, too few genes (review). Am. J. Hum. Genet., 67: 1367-1375, 2000.
22. Rebbeck. T. R., Walker, A. H., Zeigler-Johnson, C., Weisburg, S., Martin, A-M., Nathanson, K. L., Wein, A. J., and Malkowicz, S. B. Association of HPC2/ELAC2 genotypes and prostate cancer. Am. J. Hum. Genet., 67: 1014-1019, 2000.
23. Suarez, B. K., Gerhard, D. S., Lin, J., Haberer, B., Nguyen, L., Kesterson, N. K., and Catalona, W. J. Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. Cancer Res., 61: 4982-4984, 2001.
24. Vesprini, D., Nam, R. K., Trachtenberg, J., Jewett, M. A. S., Tavtigian, S. V., Emami, M., Ho, M., Toi, A., and Narod, S. A. HPC2 variants and screen-detected prostate cancer. Am. J. Hum. Genet., 68: 912-917, 2001.
25. Xu, J., Zheng, S. L., Carpten, J. D., Nupponen, N. N., Robbins, C. M., Mestre, J., Moses, T. Y., Faith, D. A., Kelly, B. D., Isaacs, S. D., Wiley, K. E., Ewing, C. M., Bujnovszky, P., Chang, B., Bailty-Wilson, J., Bleecker, E. R., Walsh, P. C., Trent, J. M., Meyers, D. A., and Isaacs, W. B. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am. J. Hum. Genet., 68: 901-911, 2001.
26. Rokman, A., Ikonen, T., Mononen, N., Autio, V., Matikainen, M. P., Koivisto, P. A., Tammela, T. L. J., Kallioniemi, O. P., and Schleutker, J. ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res., 61: 6038-6041, 2001.
27. Wang, L., McDonnell, S. K., Elkins, D. A., Slager, S. L., Christensen, E., Marks, A. F., Cunningham, J. M., Peterson, B. J., Jacobsen, S. J., Cerhan, J. R., Blute, M. L., Schaid, D. J., and Thibodeau, S. N. Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res., 61: 6494-6499, 2001.
28. Meitz, J. C., Edwards, S. M., Easton, D. F., Murkin, A., Arden-Jones, A., Jackson, R. A., Williams, S., Dearnaley, D. P., Stratton, M. R., Houlston, R. S., The Cancer Res. UK/BPG UK Familial Prostate Cancer Study Collaborators, and Eeles, R. A. HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age and onset of disease. Br. J. Cancer, 87: 905-908, 2002.
29. Stanford, J. L., Wicklund, K. G., McKnight, B., Daling, J. R., and Brawer, M. K. Vasectomy and risk of prostate cancer. Cancer Epidemiol. Bjomark. Prev., 8: 881-886, 1999.
30. Waksberg, J. Sampling methods for random digit dialing. J. Am. Stat. Assoc., 73: 40-46, 1978.
31. Gordon, D., Abajian, C., and Green, P. Consed: a graphical tool for sequence finishing. Genome Res, 8: 195-202, 1998.
32. Ewing, B., Hillier, L., Wendl, M. C., and Green, P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res., 8: 175-185. 1998.
33. Ewing, B., and Green, P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res., 8: 186-194. 1998.
34. Breslow, N. E., and Day, N. E. Statistical methods in cancer research, volume I - the analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980.
35. Dubin, N., and Pasternack, B. S. Risk assessment for case-control subgroups by polychotomous logistic regression. Am. J. Epidemiol., 123: 1101-1117, 1986.
36. Stanford, J. L., Stephenson, R. A., Coyle, L. M., Cerhan, J., Correa, R., Eley, J. W., Gilliland, F., Hankey, B., Kolonel, L. N., Kosary, C., Ross, R., Severson, R., and West, D. Prostate Cancer Trends 1973-1995, SEER Program, National Cancer Institute, NIH Publ. No. 99-4543. Bethesda, MD: National Cancer Institute, 1999.
37. Wacholder, S., Rothman, N., and Caporaso, N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J. Natl. Cancer Inst. (Bethesda), 92: 1151-1158, 2000.
38. Ries, L., Eisner, M. P., Kosary, C. L., Hankey, B. F., Miller, B. A., Clegg, L., and Edwards, B. K. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2002.